Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about GSDME: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
GSDME (Gasdermin E/DFNA5) encodes a pore-forming protein executing pyroptosis, implicated in neuronal death in AD, PD, ALS, and stroke.
| Gene Symbol | GSDME |
| Full Name | GSDME — Gasdermin E |
| Aliases | Gasdermin E/DFNA5 |
| Chromosome | 7p15.3 |
| Protein Type | Gene |
| Function | Caspase-3 cleavage: Unlike GSDMD, GSDME is cleaved by executioner caspase-3 |
| Primary Expression | cochlea, brain, and other tissues |
| Molecular Weight | 55 kDa |
| Amino Acids | 496 aa |
| Exons | 12 |
| Pathways | Pyroptosis |
| UniProt ID | [O60443](https://www.uniprot.org/uniprotkb/O60443) |
| NCBI Gene ID | Search NCBI |
| GeneCards | GSDME |
| Human Protein Atlas | GSDME |
| Associated Diseases | Amyotrophic Lateral Sclerosis, Axon Loss, Cancer, Frontotemporal Dementia, Melanoma, Pyroptosis |
| Known Drugs/Compounds | Celastrol, XHP |
| Interactions | STAT3, CD8, STING, DRP1, UBIQUITIN, SIRT1 |
| KG Connections | 263 knowledge graph edges |
| Databases | GeneCardsHPASTRING |
Knowledge base pages for this entity
graph TD
GSDME["<b>GSDME</b>"]
Cancer{"Cancer"}
GSDME -->|"activates"| Cancer
Ms{"Ms"}
GSDME -->|"activates"| Ms
Tumor{"Tumor"}
GSDME -->|"activates"| Tumor
GSDME -->|"inhibits"| Cancer
Als{"Als"}
GSDME -->|"activates"| Als
GSDME -->|"therapeutic target"| Ms
Atherosclerosis{"Atherosclerosis"}
GSDME -->|"activates"| Atherosclerosis
Cardiovascular{"Cardiovascular"}
GSDME -->|"regulates"| Cardiovascular
GSDME -->|"regulates"| Atherosclerosis
Leukemia{"Leukemia"}
GSDME -->|"activates"| Leukemia
Carcinoma{"Carcinoma"}
GSDME -->|"inhibits"| Carcinoma
ALS{"ALS"}
GSDME -->|"degrades"| ALS
CALR["CALR"]
CALR -->|"activates"| GSDME
NLRP3["NLRP3"]
NLRP3 -->|"expressed in"| GSDME
NLRP3 -->|"regulates"| GSDME
GENES["GENES"]
GENES -->|"activates"| GSDME
CD8["CD8"]
CD8 -->|"activates"| GSDME
PYROPTOSIS["PYROPTOSIS"]
PYROPTOSIS -->|"activates"| GSDME
PYROPTOSIS -->|"inhibits"| GSDME
PJA1["PJA1"]
PJA1 -->|"inhibits"| GSDME
PHAGOCYTOSIS["PHAGOCYTOSIS"]
PHAGOCYTOSIS -->|"activates"| GSDME
STAT3["STAT3"]
STAT3 -->|"activates"| GSDME
AND["AND"]
AND -->|"activates"| GSDME
CANCER["CANCER"]
CANCER -->|"activates"| GSDME
style GSDME fill:#1a3a4a,stroke:#4fc3f7,stroke-width:3px,color:#e0e0e0| Target | Relation | Type | Str |
|---|---|---|---|
| Pyroptosis | activates | pathway | 1.00 |
| PYROPTOSIS | activates | gene | 1.00 |
| pyroptosis | associated_with | process | 0.98 |
| Tumor Growth | inhibits | phenotype | 0.95 |
| Tumor Suppressor | associated_with | biomarker | 0.95 |
| Mitochondrial Damage | mediates | process | 0.95 |
| Anti-Tumor Immunity | activates | process | 0.95 |
| Mitochondrial Depolarization | mediates | process | 0.95 |
| Cancer | activates | disease | 0.95 |
| Tumor | activates | disease | 0.95 |
| Als | activates | disease | 0.95 |
| Neuron | expressed_in | cell_type | 0.95 |
| pyroptosis | mediates | process | 0.95 |
| Axon Loss | causes | phenotype | 0.90 |
| Axon Loss | involved_in | phenotype | 0.90 |
| Amyotrophic Lateral Sclerosis | involved_in | disease | 0.90 |
| Pyroptosis | mediates | process | 0.90 |
| Amyotrophic Lateral Sclerosis | associated_with | disease | 0.90 |
| CD8+ T Lymphocytes | modulates | cell_type | 0.85 |
| Natural Killer Cells | modulates | cell_type | 0.85 |
| Mitochondrial Depolarization | associated_with | process | 0.85 |
| Neurite Retraction | mediates | phenotype | 0.85 |
| CD8+ T Lymphocyte Infiltration | associated_with | process | 0.85 |
| Macrophage Phagocytosis | associated_with | process | 0.85 |
| Cancer | associated_with | disease | 0.85 |
| Phagocytosis | associated_with | process | 0.85 |
| Frontotemporal Dementia | associated_with | disease | 0.85 |
| Tumor-Associated Macrophages | modulates | cell_type | 0.80 |
| mitochondrial damage | causes | process | 0.80 |
| pyroptosis | participates_in | pathway | 0.80 |
| CANCER | activates | gene | 0.80 |
| ROS | activates | gene | 0.80 |
| CD8 | activates | gene | 0.70 |
| STING | activates | gene | 0.70 |
| UBIQUITIN | activates | gene | 0.70 |
| Apoptosis | activates | pathway | 0.70 |
| Inflammasome | activates | pathway | 0.70 |
| CYTOKINES | activates | gene | 0.70 |
| GENES | activates | gene | 0.70 |
| apoptosis pathway | participates_in | pathway | 0.70 |
| oxidative stress response | participates_in | pathway | 0.70 |
| pyroptosis | activates | process | 0.70 |
| Ms | activates | disease | 0.65 |
| Cancer | inhibits | disease | 0.65 |
| Ms | therapeutic_target | disease | 0.65 |
| Atherosclerosis | activates | disease | 0.65 |
| Cardiovascular | regulates | disease | 0.65 |
| Atherosclerosis | regulates | disease | 0.65 |
| Leukemia | activates | disease | 0.65 |
| Carcinoma | inhibits | disease | 0.65 |
| Source | Relation | Type | Str |
|---|---|---|---|
| p53 | activates | protein | 0.95 |
| CASP3 | activates | gene | 0.95 |
| Celastrol | activates | compound | 0.95 |
| XHP | activates | drug | 0.95 |
| NLRP3-Caspase inflammatory signaling | activates | pathway | 0.92 |
| GRZB | cleaves | enzyme | 0.90 |
| GRANZYME B | cleaves | enzyme | 0.90 |
| CASP3 | associated_with | protein | 0.90 |
| reactive oxygen species | cleaves | process | 0.88 |
| STAT3 | regulates | entity | 0.85 |
| TDP-43 | activates | protein | 0.85 |
| CALR | activates | gene | 0.60 |
| NLRP3 | expressed_in | gene | 0.60 |
| NLRP3 | regulates | gene | 0.60 |
| CD8 | activates | gene | 0.60 |
| PJA1 | inhibits | gene | 0.60 |
| STAT3 | activates | gene | 0.60 |
| BAX | activates | gene | 0.60 |
| STING | activates | gene | 0.60 |
| JNK | therapeutic_target | gene | 0.60 |
| SOD1 | associated_with | gene | 0.60 |
| AKT | activates | gene | 0.60 |
| CD31 | associated_with | gene | 0.60 |
| GSDMD | activates | gene | 0.60 |
| GSDMD | associated_with | gene | 0.60 |
| GENES | activates | gene | 0.60 |
| PYROPTOSIS | activates | gene | 0.60 |
| PYROPTOSIS | inhibits | gene | 0.60 |
| PHAGOCYTOSIS | activates | gene | 0.60 |
| CANCER | activates | gene | 0.60 |
| APOPTOSIS | activates | gene | 0.60 |
| ROS | activates | gene | 0.60 |
| CANCER | inhibits | gene | 0.60 |
| APOPTOSIS | associated_with | gene | 0.60 |
| NAD | activates | gene | 0.60 |
| AND | activates | gene | 0.60 |
| IMMUNE INFILTRATION | activates | gene | 0.60 |
| INFLAMMATION | activates | gene | 0.60 |
| APOPTOSIS | therapeutic_target | gene | 0.60 |
| CYTOKINES | activates | gene | 0.60 |
| AND | associated_with | gene | 0.60 |
| PYROPTOSIS | regulates | gene | 0.60 |
| MITOCHONDRIA | activates | gene | 0.60 |
| ERK | associated_with | gene | 0.60 |
| ROS | therapeutic_target | gene | 0.60 |
| INFLAMMATION | regulates | gene | 0.60 |
| APOPTOSIS | expressed_in | gene | 0.60 |
| CANCER | associated_with | entity | 0.60 |
| ALS | activates | entity | 0.60 |
| FTD | activates | entity | 0.60 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| No targeting hypotheses | |||
Scientific analyses that reference this entity
No analyses mention this entity
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||